Home   >  
TGF beta/Smad
  • Wnt/Stem Cell
  >  
BMP/TGF beta Receptor
  • TGF β/Smad
  >   Galunisertib
Galunisertib Chemical Structure

Galunisertib

Data Sheet For research use only. Not for human use.
Cat. No. :BCP02173CAS No. :700874-72-2Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Publications Citing of Biochempartner's Galunisertib
  • Chemical Properties&Biological Activity
CAS No. 700874-72-2 Cat. No. BCP02173
Name Galunisertib
Synonyms LY2157299; LY-2157299; LY 2157299;
SMILES CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N
Chemical Name
Formula C22H19N5O M. Wt 369.42
Purity 98% Storage Store at 4-8°C
Description LY2157299 potently inhibits the TGFβ receptor signaling. LY2157299 abolishes the TGFβ induced Smad2 phosphorylation in HUVEC cells. LY2157299 also shows dose dependent potentiation of VEGF or bFGF induced cell proliferation in HUVEC. LY2157299 also promotes VEGF induced HUVEC cell migration. LY2157299 potentiates angiogenesis in the in vitro VEGF-stimulated cord formation assay. LY2157299 inhibits TGF-β-mediated SMAD2 activation and hematopoietic suppression in primary hematopoietic stem cells in a dose-dependent manner. LY2157199 treatment stimulates hematopoiesis from primary MDS bone marrow specimens.In human glioblastoma (GBM) cells, LY2157299 treatment blocks signaling through the heteromeric TGFβ receptor complex to reduce levels of active, phosphorylated SMAD.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Galunisertib supplier,Galunisertib purchase,Galunisertib manufacturer,Galunisertib distributor,Galunisertib cost,Galunisertib buy,Galunisertib for sale

0086-13720134139